Suppresses absorption of Magnesium. This medication is commonly used for High Cholesterol
Magnesium supplements and statin medications both inhibit the HMG-CoA and have complementary effects to reducing the production of cholesterol. Magnesium has functions that are crucial to cardiovascular and general health as a catalyst to 300 healthy reactions in the body and 100 in the heart. The association between Magnesium supplementation and statins is also able to offer some protection for painful myopathy as a side effect induced by statins, which may also boost patient compliance. According to research, patients who received the statin drug atorvastatin along with a magnesium treatment had significantly increased levels of serum magnesium, HDL (the good cholesterol), as well as significantly decreased levels of total cholesterol, LDL cholesterol, and triglycerides.
Roxana Nartea, et al. The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients. Curr Issues Mol Biol. 2023 Apr; 45(4): 3146–3167. Published online 2023 Apr 5. doi: 10.3390/cimb45040205. El-Haggar Sahar M., Mostafa Tarek M. Role of Magnesium Supplement on Hyperlipidemia and L-CAT Level in Patient on Atorvastatin Therapy. Br. J. Pharm. Res. 2014;4:1521–1534. doi: 10.9734/BJPR/2014/11159
Magnesium — 75mg
Low or depleted magnesium levels are associated with a higher likelihood of several cardiovascular problems, including arrhythmias, where people with low magnesium have been shown to have 2–4 times higher odds of these rhythm disturbances compared with those with normal levels. Low magnesium is also linked to worsening coronary artery disease, progression of heart failure, and development or aggravation of hypertension, driven by disrupted cardiac electrical stability, vascular function, and electrolyte balance. Even mild magnesium depletion may contribute to higher blood pressure over time, adding to the overall cardiovascular burden, especially in individuals with existing heart disease or multiple risk factors.
Low or depleted magnesium levels place people with diabetes and metabolic syndrome (MetSyn) at higher risk of worsening glycemic control and insulin resistance because magnesium is essential for normal glucose metabolism and beta-cell function. When magnesium is low, these metabolic pathways become less efficient, amplifying blood sugar instability, lipid abnormalities, and other MetSyn features. Even moderate depletion can accelerate type 2 diabetes and MetSyn-related complications, underscoring the need for monitoring magnesium status in these vulnerable groups.
Low or depleted magnesium levels are associated with a higher risk of osteoporosis and fractures, with studies linking magnesium deficiency to a 25–35% increased risk of hip, wrist, and spine fractures in some populations. Magnesium deficiency impairs bone mineralization and vitamin D activation, compounding skeletal weakness by disrupting osteoblast function and calcium balance. This is particularly concerning for older adults or those with additional risk factors, where monitoring magnesium status and considering supplementation may help mitigate bone loss.
Magnesium depletion can contribute to neurological issues like migraines, depression, seizures, and cognitive impairment by disrupting neuronal excitability, neurotransmitter balance, and NMDA receptor function. Case reports often describe severe symptoms such as tremors, encephalopathy, cerebellar ataxia, or memory problems in affected patients, which typically resolve once magnesium levels are restored. Although these effects occur less frequently than cardiovascular complications, monitoring is advisable particularly in older adults with persistent low magnesium.
Magnesium (as Magnesium Citrate) by Pure Encapsulations — 150 mg